SOME METABOLIC CHARACTERISTICS OF LOW-DENSITY LIPOPROTEIN SUBFRACTIONS, LDL-1 AND LDL-2 - INVITRO AND INVIVO STUDIES

被引:28
|
作者
SWINKELS, DW
DEMACKER, PNM
HAKLEMMERS, HLM
MOL, MJTM
YAP, SH
VANTLAAR, A
机构
[1] CATHOLIC UNIV NIJMEGEN,DEPT MED,DIV GEN INTERNAL MED,NIJMEGEN,NETHERLANDS
[2] CATHOLIC UNIV NIJMEGEN,DIV GASTROINTESTINAL & LIVER DIS,NIJMEGEN,NETHERLANDS
关键词
D O I
10.1016/0005-2760(88)90002-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [41] Autoantibodies against oxidized low-density lipoprotein (ox-LDL) and LDL oxidation status
    Brizzi, P
    Tonolo, G
    Bertrand, G
    Carusillo, F
    Severino, C
    Maioli, M
    Malaguarnera, L
    Musumeci, S
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (02) : 164 - 170
  • [42] LOW-DENSITY LIPOPROTEIN (LDL)-BASED SYNTHETIC PEPTIDES SHARE ANTIGENIC DETERMINANTS WITH NATIVE LDL
    BENZ, MW
    LEES, RS
    SHIH, IL
    TAYLOR, JW
    LEES, AM
    ARTERIOSCLEROSIS, 1989, 9 (05): : A726 - A726
  • [43] Oxidized low-density lipoprotein (LDL) and LDL cholesterol are associated with outcomes of minor stroke and TIA
    Wang, Anxin
    Dai, Liye
    Zhang, Nan
    Lin, Jinxi
    Chen, Guojuan
    Zuo, Yingting
    Li, Hao
    Wang, Yilong
    Meng, Xia
    Wang, Yongjun
    ATHEROSCLEROSIS, 2020, 297 : 74 - 80
  • [44] Low-Density Lipoprotein Cholesterol (LDL-C): How Low?
    Whayne, Thomas F., Jr.
    CURRENT VASCULAR PHARMACOLOGY, 2017, 15 (04) : 374 - 379
  • [45] LOVASTATIN THERAPY APPEARS TO REDUCE THE INVIVO AFFINITY OF LOW-DENSITY LIPOPROTEINS (LDL) FOR THE LDL RECEPTOR
    GINSBERG, H
    CHANDRASHEKAR, P
    BERGLUND, L
    RAMAKRISHNAN, R
    WITZTUM, J
    ARTERIOSCLEROSIS, 1989, 9 (05): : A708 - A708
  • [46] 'Danger' effect of low-density lipoprotein (LDL) and oxidized LDL on human immature dendritic cells
    Zaguri, R.
    Verbovetski, I.
    Atallah, M.
    Trahtemberg, U.
    Krispin, A.
    Nahari, E.
    Leitersdorf, E.
    Mevorach, D.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 149 (03): : 543 - 552
  • [47] Novel low-density lipoprotein (LDL) oxidation model: Antioxidant capacity for the inhibition of LDL oxidation
    Chu, YF
    Liu, RH
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2004, 52 (22) : 6818 - 6823
  • [48] THE CHARACTERISTICS OF LOW-DENSITY LIPOPROTEIN (LDL) PARTICLE SIZE IN HYPERCHOLESTEROLEMIC PATIENTS WITH CHRONIC GLOMERULONEPHRITIS
    Yasuda, Gen
    Masuda, Shin-Ichiro
    Hirawa, Nobuhito
    Ando, Daisaku
    Endo, Teruhiko
    Dejima, Kyoko
    Umemura, Satoshi
    NEPHROLOGY, 2005, 10 : A273 - A273
  • [49] Oxidized Low-Density Lipoprotein (ox-LDL) to LDL Ratio (ox-LDL/LDL) and ox-LDL to High-Density Lipoprotein Ratio (ox-LDL/HDL): Are they Accurate Biomarkers of Type 2 Diabetes Mellitus?
    Motamed, Mahtab
    Nargesi, Arash A.
    Heidari, Behnam
    Mirmiranpour, Hossein
    Esteghamati, Alireza
    Nakhjavani, Manouchehr
    CLINICAL LABORATORY, 2016, 62 (09) : 1609 - 1617
  • [50] QUANTITATION OF VERY LOW-DENSITY (VLDL) TO LOW-DENSITY LIPOPROTEIN (LDL) IN NORMAL AND HYPERLIPEMIC MAN
    JANUS, E
    WOOTTON, R
    NICOLL, A
    TURNER, P
    LEWIS, B
    CIRCULATION, 1977, 56 (04) : 21 - 21